Infliximab prevents Crohn's disease recurrence after ileal resection

Expert Review of Gastroenterology and Hepatology

Volumn 3, Issue 3, 2009, Pages 231-234

  Cottone, Mario ^a,b   Mocciaro, Filippo ^a   Orlando, Ambrogio ^a  

^a UNIVERSITY OF PALERMO   (Italy)

^b NONE   (Italy)

Author keywords

Crohn's disease; Endoscopic recurrence; Ileal resection; Infliximab

Indexed keywords

AZATHIOPRINE; IMMUNOMODULATING AGENT; INFLIXIMAB; MESALAZINE; PLACEBO;

ARTICLE; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; COLONOSCOPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROHN DISEASE; DISEASE SEVERITY; DRUG WITHDRAWAL; ENDOSCOPY; HUMAN; ILEUM RESECTION; NEUTROPHIL CHEMOTAXIS; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; RELAPSE; REMISSION; UNSPECIFIED SIDE EFFECT;

EID: 69949178291     PISSN: 17474124     EISSN: None     Source Type: Journal    
DOI: 10.1586/egh.09.13     Document Type: Article

References (15)

1. Rutgeerts P, Geboes K, Vantrappen G et al. Predictability of the postoperative course of Crohn's disease. Gastroenterology 99, 956-963 (1990).
2. Renna S, Cammà CM, Modesto I et al. Meta-analysis of the placebo rate of clinical relapse and severe endoscopic recurrence in post-operative Crohn's disease. Gastroenterology 135, 1500-1509 (2008).
3. Cammà CM. Mesalamine and relapse prevention in Crohn's disease. Gastroenterology 119, 597 (2000).
4. Cammà C, Viscido A, Latella G, Caprilli R, Cottone M. Mesalamine in the prevention of clinical and endoscopic postoperative recurrence of Crohn's disease: a metaanalysis. Dig. Liver Dis. 34, A86 (2002).
5. Rutgeerts P, Van Assche G, Vermeire S et al. Ornidazole for prophylaxis of postoperative Crohn's disease recurrence: a randomized, double-blind, placebo-controlled trial. Gastroenterology 128, 856-861 (2005).
6. Rutgeerts P, Hiele M, Geboes K et al. Controlled trial of metronidazole treatment for prevention of Crohn's recurrence after ileal resection. Gastroenterology 108, 1617-1621 (1995).
7. Hanauer S, Korelitz BI, Rutgeerts P et al. Postoperative maintenance of Crohn's disease remission with 6-mercaptopurine, mesalamine, or placebo: a 2-year trial. Gastroenterology 127, 723-729 (2004).
8. Ardizzone S, Maconi G, Sampietro GM et al. Azathioprine and mesalamine for prevention of relapse after conservative surgery in Crohn's disease. Gastroenterology 127, 730-740 (2004).
9. D'Haens G, Baert F, Van Assche G et al. Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial. Lancet 371, 660-667 (2008).
10. Sorrentino D, Terrosu G, Avellini C et al. Prevention of post-operative recurrence of Crohn's disease by infliximab. Arch. Intern. Med. 167, 1804-1180 (2007).
11. Regueiro M, Schraut W, Baidoo L. Infliximab prevents Crohn's disease recurrence after ileal resection. Gastroenterology 136, 441-450 (2009).
12. D'Haens GR, Vermeire S, Van Assche G et al. Therapy of metronidazole with azathioprine to prevent postoperative recurrence of Crohn's disease: a controlled randomized trial. Gastroenterology 135, 1123-1129 (2008).
13. Wang R, Lagakos SW, Ware JH et al. Statistics in medicine - reporting of subgroup analyses in clinical trials. N. Engl. J. Med. 357, 2189-2194 (2007).
14. Caprilli R, Gassul MA, Escher JC et al. European evidence based consensus on the diagnosis and management of Crohn's disease: special situations. Gut 55(Suppl. I), I36-I58 (2006).
15. Yamamoto T, Umegae S, Matsumoto K. Impact of infliximab therapy after early endoscopic recurrence following ileocolonic resection of Crohn's disease: a prospective pilot study. Inflamm. Bowel Dis. DOJ: 10.1002/ibd.20915 (2009).